Dr. Sharon Dell, The Hospital for Sick Children, Toronto, ON

Children’s interstitial lung disease (chILD) is rare but associated with the highest mortality of all pediatric chronic lung diseases. Multicenter clinical research networks have provided the infrastructure for driving advances in this field. Modern genome sequencing techniques have revealed novel mechanisms of disease in chILD. This session will briefly review the basic epidemiology, diagnosis and management of children’s interstitial lung disease (chILD) and then focus on recent literature advancing the field.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • know the classification of children’s ILD (chILD) by age group;
  • recognize clinical manifestations and prognosis of NEHI, PIG, ABCA3 and other chILD from recent literature; and
  • learn about new chILD (kids) on the block.